FDA offers webinar series on ClinicalTrials.gov

The FDA has provided a three-part webinar series on ClinicalTrials.gov: a general overview and relevant definitions, laws, and regulations for complying with ClinicalTrials.gov registration and results information submission requirements.

Participants will gain an understanding of CDER's role and responsibilities with respect to ClinicalTrials.gov oversight and will hear examples of compliance and enforcement activities CDER has taken to encourage compliance.

Intended Audience

• Sponsors, sponsor-investigators and clinical investigators designated as responsible for submitting registration and results information to ClinicalTrials.gov

Topics Covered

• FDA's roles and responsibilities with respect to ClinicalTrials.gov oversight
• An overview of ClinicalTrials.gov definitions, laws, and regulations
• An overview of CDER's compliance and enforcement activities with respect to ClinicalTrials.gov requirements, including case examples

FDA Resources

• FDA's Role: ClinicalTrials.gov Information

Webinars